SEC Form 4 · accession 0001161697-16-000598
CATALYST PHARMACEUTICALS, INC. · CPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles B O'Keeffe
Director
Period of report
Dec 30, 2015
Accepted (ET)
Jan 4, 2016 · 4:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369568
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to purchase common stock | $2.53 | Dec 30, 2015 | A | 20,000 | A | Dec 30, 2015 | Dec 30, 2022 | Common Stock | 20,000 | 150,000 | D |
| Options to purchase common stock | $2.53 | Dec 30, 2015 | A | 20,000 | A | Dec 30, 2016 | Dec 30, 2022 | Common Stock | 20,000 | 170,000 | D |